ResMed Inc. Financials

Market Capitalization $37.52 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	28.69
Forward PE	24.87
Price to Sales TTM	$7.47
Price to Book MRQ	$6.76
Enterprise to Revenue	7.51
Enterprise to EBITDA	21.38

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2021-06-30
Most Recent Quarter	2025-03-31
Profit Margin	26.15%
Operating Margin	33.00%
Return on Assets TTM	14.01%
Return on Equity TTM	25.81%

Income Statement

Revenue TTM	$5,021,529,088
Revenue per Share TTM	$34.20
Quarterly Revenue Growth	7.90%
Gross Profit TTM	$2,981,164,032
EBITDA	$1,754,702,000
Net Income to Common TTM	$1,313,254,016
Diluted EPS TTM	$8.92
Quarterly Earnings Growth YoY	21.50%

Balance Sheet

Total Cash MRQ	$944,841,984
Total Cash per Share MRQ	$6.44
Total Debt MRQ	$
Total Debt to Equity MRQ	15.14
Current Ratio MRQ	3.41
Book Value per Share MRQ	$37.83

Cash Flow

Operating Cash Flow TTM	$1,652,935,936
Levered Free Cash Flow TTM	$1,202,870,656

RMD Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	146,901,045
Float Shares	145,702,180
Avg 10 Volume	919,193
Avg 30 Volume	None
Shares Short	9,929,357
Short Ratio	11.58
Short % of Shares	7.79%
% Held by Insiders	0.66%
% Held by Institutions	65.45%

Stock Price Summary

Beta	0.77
Fifty Two Week Low	$188.56
Fifty Two Week High	$263.05
Fifty Two Week Change	24.21%
Day 50 MA	$245.41
Day 200 MA	$238.25

Dividends and Splits

Forward Annual Dividend Rate	$2.12
Forward Annual Dividend Yield	0.83%
Trailing Annual Dividend Rate	$2.07
Trailing Annual Dividend Yield	0.81%
Payout Ratio	23.23%
Dividend Date	2025-06-12
Ex Dividend Date	2025-05-08
Last Split Factor
Last Split Date	2010-08-31